Unlock instant, AI-driven research and patent intelligence for your innovation.

Labeled swine fever virus E2 protein recombinant baculovirus inactivated vaccine

A technology of recombinant baculovirus and swine fever virus, which is applied in the field of vaccines, can solve the problems of contaminating bovine viral diarrhea, affecting the safety of vaccines, and the inability of Erns antibodies to effectively carry out differential diagnosis, and achieve the effect of effective purification.

Active Publication Date: 2021-02-19
天康生物制药有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The first production method requires a large number of rabbits to collect antigens. In addition, due to the influence of individual differences in rabbits, the quality of antigens is uneven, which ultimately affects the effect of the vaccine.
The second production method requires the use of bovine serum in the production process. Bovine serum not only introduces heterologous animal protein into the product, but also may contaminate bovine viral diarrhea, which affects the safety of the vaccine.
Immunization with swine fever E2 subunit vaccine twice can produce effective protection under virulent attack; although it can be differentially diagnosed by swine fever Erns antibody, due to the short duration of Erns antibody and even some strains cannot produce Erns antibody, it is necessary to use Erns antibody ineffective differential diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Labeled swine fever virus E2 protein recombinant baculovirus inactivated vaccine
  • Labeled swine fever virus E2 protein recombinant baculovirus inactivated vaccine
  • Labeled swine fever virus E2 protein recombinant baculovirus inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Example 1 Gene optimization, mutation and synthesis of classical swine fever virus E2

[0072]The published E2 sequence of classical swine fever virus and the E2 sequence of new strains popular in recent years were downloaded from Genebank as a reference, and optimized on the basis of the E2 gene of the C strain, and the optimized E2 gene was combined with the reference strains of each subgroup After comparison, the results showed that the optimized E2 gene was determined to be group 1.1. At the same time, the optimized E2 gene sequence epitope "TAVSPTTLR" was mutated into "ATVSPTTRL, TASVPTTLR, TAVSPTTRL, TAVSPTTRL, TAPVSTTRL or TASPVTTRL", and the obtained 6 optimized mutated sequences were submitted to the gene company for synthesis.

Embodiment 2

[0073] The construction of embodiment 2 transfer vectors

[0074] For the test method, refer to the Invitrogen operation manual, and the specific operation is as follows.

[0075] prepare Clone reaction mixture, its composition is as follows: 0.5~4μl synthesized E2 nucleotide, 1μl salt solution (1.2mol / LNaCl, 0.06mol / LMgCl2)), 1μl carrier, and double distilled water was added to make the total volume 6 μl. The steps of the cloning reaction are as follows: pat the wall of the centrifuge tube lightly to mix the reaction mixture evenly, let it sit at room temperature (22-23°C) for 15 minutes, and then place the reaction tube on ice. Take 2μl Add the clone reaction solution to the competent cells, pat the tube wall to mix evenly, place it on ice for 30 minutes, then place it in a water bath at 42°C for 30 seconds for heat shock, then immediately put the reaction tube back on ice Then add 250 μl of warmed SOC culture solution into the reaction tube, put it into a constant t...

Embodiment 3

[0077] Embodiment 3 Recombination of transfer vector and linear baculovirus

[0078] With the extracted recombinant vector, measure the nucleic acid concentration of the recombinant vector at a wavelength of 260nm with a spectrophotometer. Then carry out the LR recombination reaction according to the operation manual of "BaculoDirectTM Baculovirμs Expression System" provided by Invitrogen. The specific operation is as follows: 1 μl recombinant transfer vector (100-300ng), 4 μl 5×LR Reaction buffer and 1μl double distilled water were added to 10μl BaculoDirectTM linear DNA (300ng). Take out LR from -70℃ refrigerator Put the enzyme mix on ice for 2 minutes, shake twice, 2 seconds each time, take 4μl LR Add enzyme mix to the above mixture, pat the tube wall several times to make it evenly mixed, do not shake violently to avoid the baculovirus DNA fragmentation. After infecting at 25°C for 18 hours, add 2 μl of proteinase K and place it at 37°C for 10 minutes to stop the LR...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of vaccines and particularly provides a labeled swine fever virus E2 protein recombinant baculovirus inactivated vaccine. The labeled swine fever virus recombinant E2 protein is shown as SEQ ID NO.1, a nucleic acid molecular sequence for encoding the labeled swine fever virus recombinant E2 protein is shown as SEQ ID NO.2, an efficient expression of a target protein can be realized through a baculovirus-insect cell expression system, the labeled swine fever virus recombinant E2 protein can be used for preparing the labeled swine fever virus E2 proteinrecombinant baculovirus inactivated vaccine, and an immune efficacy of the inactivated vaccine equivalent to that of a subunit vaccine and a live vaccine can be achieved only by once immunization. Inaddition, an identification of a swine infection non-labeled vaccine strain or a wild strain can be realized through a detection of a WH303 antibody, so that an effective purification of swine feveris realized.

Description

technical field [0001] The invention relates to the field of vaccines, in particular to a recombinant baculovirus inactivated vaccine labeled with classical swine fever virus E2 protein. Background technique [0002] Conventional swine fever vaccine has three kinds of production methods at present, and the one, seed virus is inoculated in healthy rabbit and breeds in its body, then the spleen of gathering rabbit and lymph node are ground and freeze-dried and form. The second is to inoculate the primary cells or passage cells with the seed virus, and collect the supernatant to freeze-dry. The first production method requires a large number of rabbits to collect antigens. In addition, due to the influence of individual differences in rabbits, the quality of antigens is uneven, which ultimately affects the effect of the vaccine. The second production method requires the use of bovine serum in the production process. The bovine serum not only introduces heterologous animal prot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/18C12N15/40C12N7/01A61K39/187A61P31/14G01N33/569
CPCC07K14/005C12N7/00A61K39/12A61P31/14G01N33/56983C12N2800/22C12N2770/24322C12N2770/24334C12N2710/14021A61K2039/5252A61K2039/5256A61K2039/552G01N2333/183
Inventor 贺笋李俊辉王遵宝李延涛程兰玲刘宏郑侃王雨朦
Owner 天康生物制药有限公司